Patrick Hurban, Ph.D. | January 13, 2016

Precision Medicine - Leveraging Genomics in Clinical Research

Part one of three video blog series by Patrice Hugo, Ph.D. Chief Scientific Officer
In part one of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the significance of genomic technologies in clinical trials. Dr. Hurban shares his perspective on genomic technologies and the future of precision medicine as well as how both will impact healthcare globally.

Watch Part one